Monoclonal antibodies reduced COVID-19 hospitalization, death risk by a third: Study
During the pandemic, high-risk COVID-19 patients who received monoclonal antibodies had 39% lower risk of hospitalization or death than those who didn’t.
New York United States Studyby Elissa Wolfson Erin Mccreary Drug Administration University Of Pittsburgh School Medicine
Source: scienceboard.net